Immunotech Biopharm Ltd (hkse:06978) Share Price

Company Profile

Business description
Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.
Contact
No.1 Kangding Street
8th Floor, Block 1, Guosheng Technology Park
Beijing Economic-technological Development Area
Beijing100176
CHN
T: +86 8610884002
https://www.eaal.net
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
173

Recommended

Shares have dropped 20% in the previous year due to concerns about tariffs.

Esther Holloway | 27 October 2025

Higher gold prices are making a difference to the bottom line but investors overly optimistic.

Jon Mills, CFA | 27 October 2025

We see faster cloud growth and improved longer-term profitability for Alphabet.

Malik Ahmed Khan, CFA | 25 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,319.10	2.90	-0.03%
CAC 40	8,239.18	13.55	0.16%
DAX 40	24,308.78	68.89	0.28%
Dow JONES (US)	47,544.59	337.47	0.71%
FTSE 100	9,653.82	8.20	0.09%
HKSE	26,433.70	273.55	1.05%
NASDAQ	23,637.46	432.59	1.86%
Nikkei 225	50,512.32	1,212.67	2.46%
NZX 50 Index	13,399.02	7.43	0.06%
S&P 500	6,875.16	83.47	1.23%
S&P/ASX 200	9,040.20	11.40	0.13%
SSE Composite Index	3,996.94	46.63	1.18%